Ani Pharmaceuticals reported $-3454000 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ani Pharmaceuticals ANIP:US USD -3454000 6.78M
Aurora Cannabis Inc ACB:CN CAD -73026000 13.79M
Canopy Growth Corp WEED:CN CAD -117273000 11.22M
Eli Lilly And LLY:US USD 1.95B 294.9M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Hikma Pharmaceutical HIK:LN USD 256M 23M
Knight Therapeutics Inc GUD:CN CAD -9934000 12.27M
Lannett LCI:US USD -11277000 12.66M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Novartis NVS:US USD 3.33B 8M
Omeros OMER:US USD -50766000 13.33M
Perrigo Ordinary Shares PRGO:US USD 52.2M 49.6M
Teva Pharmaceutical TEVA:IT USD 740M 6M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M